
Navidea Biopharmaceuticals NAVB
Navidea Biopharmaceuticals PEG Ratio | NAVB
Annual PEG Ratio Navidea Biopharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.00272 | -0.00882 | -0.0187 | -0.00597 | -1.41 | 0.498 | 4.38 | -22.6 | -0.213 | 0.239 | 0.0185 | 0.408 | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.38 | -22.6 | -1.56 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Caladrius Biosciences
CLBS
|
-0.00197 | - | -16.75 % | $ 25.8 M | ||
|
Cyclacel Pharmaceuticals
CYCC
|
0 | - | -5.98 % | $ 34.1 M | ||
|
Diffusion Pharmaceuticals
DFFN
|
-0.00719 | - | 11.68 % | $ 8.97 M | ||
|
Eloxx Pharmaceuticals
ELOX
|
0.405 | - | -5.68 % | $ 8.28 M | ||
|
Enochian Biosciences
ENOB
|
-0.000004 | - | - | $ 40.5 M | ||
|
Esperion Therapeutics
ESPR
|
0.799 | - | - | $ 661 M | ||
|
Evofem Biosciences
EVFM
|
0.000199 | - | 7.55 % | $ 38.1 M | ||
|
Eyenovia
EYEN
|
-0.000013 | - | 49.81 % | $ 13.2 M | ||
|
FibroGen
FGEN
|
-0.0162 | - | - | $ 889 M | ||
|
Homology Medicines
FIXX
|
0.168 | - | 0.77 % | $ 53.4 M | ||
|
Amicus Therapeutics
FOLD
|
3.71 | - | - | $ 4.47 B | ||
|
Frequency Therapeutics
FREQ
|
-1.47 | - | - | $ 528 M | ||
|
Galecto
GLTO
|
0.563 | - | - | $ 762 M | ||
|
GlycoMimetics
GLYC
|
-19 | - | 9357.83 % | $ 1.01 B | ||
|
Graybug Vision
GRAY
|
0.122 | - | -11.23 % | $ 9.65 M | ||
|
Galera Therapeutics
GRTX
|
0.0196 | - | -32.59 % | $ 7.61 M | ||
|
Happiness Biotech Group Limited
HAPP
|
-0.156 | - | 1.35 % | $ 17.8 M | ||
|
Novavax
NVAX
|
-0.0736 | $ 7.47 | -3.24 % | $ 1.21 B | ||
|
Hepion Pharmaceuticals
HEPA
|
-0.000031 | - | -18.79 % | $ 39.3 K | ||
|
Hoth Therapeutics
HOTH
|
-0.00188 | - | - | $ 18.8 M | ||
|
IMARA
IMRA
|
-0.0707 | - | 15.96 % | $ 663 M | ||
|
KalVista Pharmaceuticals
KALV
|
-3.51 | - | - | $ 1.45 B | ||
|
KemPharm
KMPH
|
0.0352 | - | -0.34 % | $ 200 M | ||
|
Kezar Life Sciences
KZR
|
-0.00435 | - | - | $ 53.3 M | ||
|
Lixte Biotechnology Holdings
LIXT
|
0.0152 | - | - | $ 63.4 M | ||
|
Magenta Therapeutics
MGTA
|
-0.000467 | - | -7.74 % | $ 41.6 M | ||
|
NovaBay Pharmaceuticals
NBY
|
-0.000013 | - | - | $ 11.3 M | ||
|
NeuroBo Pharmaceuticals
NRBO
|
-0.00875 | - | 0.43 % | $ 12 M | ||
|
OncoCyte Corporation
OCX
|
-0.000001 | - | 17.22 % | $ 355 K | ||
|
Onconova Therapeutics
ONTX
|
-0.000018 | - | -0.47 % | $ 21 M | ||
|
Opthea Limited
OPT
|
-0.000183 | - | - | $ 1.2 B | ||
|
Verastem
VSTM
|
-0.00825 | $ 6.33 | -7.8 % | $ 439 M | ||
|
BiomX
PHGE
|
-0.000755 | $ 1.85 | 14.2 % | $ 3.02 M | ||
|
Pieris Pharmaceuticals
PIRS
|
-0.00912 | - | -15.58 % | $ 1.22 B | ||
|
Plus Therapeutics
PSTV
|
-0.0068 | - | - | $ 301 M | ||
|
Pluristem Therapeutics
PSTI
|
-0.00473 | - | -1.9 % | $ 33.3 M | ||
|
Qualigen Therapeutics
QLGN
|
-0.000099 | - | 5.59 % | $ 1.16 M | ||
|
Cassava Sciences
SAVA
|
-0.0148 | - | - | $ 110 M | ||
|
Selecta Biosciences
SELB
|
0.000006 | - | -8.69 % | $ 126 M | ||
|
Sangamo Therapeutics
SGMO
|
0.181 | - | - | $ 50.4 M | ||
|
Salarius Pharmaceuticals
SLRX
|
-0.000055 | - | - | $ 2.64 M | ||
|
Sonnet BioTherapeutics Holdings
SONN
|
-0.000448 | - | - | $ 826 K | ||
|
Synthetic Biologics
SYN
|
-0.000109 | - | 1.32 % | $ 16.2 M | ||
|
Synlogic
SYBX
|
-0.00324 | - | - | $ 7.07 M | ||
|
Virios Therapeutics, LLC
VIRI
|
0.0102 | - | 2710.01 % | $ 72.9 M | ||
|
Vaxart
VXRT
|
-0.583 | - | -25.06 % | $ 46.3 M | ||
|
XOMA Corporation
XOMA
|
-0.307 | - | - | $ 485 M |